Benzimidazole derivatives as potential dual inhibitors for PARP-1 and DHODH

• Main Authors: Abdullah, I., Chee, C.F., Lee, Y.-K., Thunuguntla, S.S.R., Satish Reddy, K., Nellore, K., Antony, T., Verma, J., Mun, K.W., Othman, S., Subramanya, H., Rahman, N.A.
• Format: Article
• Language: English
• Published: 2017

Poly (ADP-ribose) polymerases (PARPs) play diverse roles in various cellular processes that involve DNA repair and programmed cell death. Amongst these polymerases is PARP-1 which is the key DNA damage-sensing enzyme that acts as an initiator for the DNA repair mechanism. Dihydroorotate dehydrogenase (DHODH) is an enzyme in the pyrimidine biosynthetic pathway which is an important target for anti-hyperproliferative and anti-inflammatory drug design. Since these enzymes share a common role in the DNA replication and repair mechanisms, it may be beneficial to target both PARP-1 and DHODH in attempts to design new anti-cancer agents. Benzimidazole derivatives have shown a wide variety of pharmacological activities including PARP and DHODH inhibition. We hereby report the design, synthesis and bioactivities of a series of benzimidazole derivatives as inhibitors of both the PARP-1 and DHODH enzymes. © 2015 Elsevier Ltd. All rights reserved.